This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nogueira, P. A.
Right arrow Articles by del Portillo, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nogueira, P. A.
Right arrow Articles by del Portillo, H. A.

 Previous Article  |  Next Article 

Infection and Immunity, May 2006, p. 2726-2733, Vol. 74, No. 5
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.5.2726-2733.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1{dagger}

Paulo Afonso Nogueira,1,{ddagger} Fabiana Piovesan Alves,2,{ddagger} Carmen Fernandez-Becerra,2 Oliver Pein,2,§ Neida Rodrigues Santos,1 Luiz Hildebrando Pereira da Silva,1 Erney Plessman Camargo,2 and Hernando A. del Portillo2*

Instituto de Pesquisa em Patologias Tropicais, Estrada BR 364-Km 4,5, Porto Velho, Rondônia 78900-000,1 Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Av. Lineu Prestes 1374, São Paulo SP 05508-900, Brazil2

Received 20 July 2005/ Returned for modification 29 August 2005/ Accepted 22 February 2006

Progress towards the development of a malaria vaccine against Plasmodium vivax, the most widely distributed human malaria parasite, will require a better understanding of the immune responses that confer clinical protection to patients in regions where malaria is endemic. The occurrence of clinical protection in P. vivax malaria in Brazil was first reported among residents of the riverine community of Portuchuelo, in Rondônia, western Amazon. We thus analyzed immune sera from this same human population to determine if naturally acquired humoral immune responses against the merozoite surface protein 1 of P. vivax, PvMSP1, could be associated with reduced risk of infection and/or clinical protection. Our results demonstrated that this association could be established with anti-PvMSP1 antibodies predominantly of the immunoglobulin G3 subclass directed against the N terminus but not against the C terminus, in spite of the latter being more immunogenic and capable of natural boosting. This is the first report of a prospective study of P. vivax malaria demonstrating an association of reduced risk of infection and clinical protection with antibodies against an antigen of this parasite.


* Corresponding author. Mailing address: Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Av. Lineu Prestes 1374, São Paulo SP 05508-900, Brasil. Phone: 55-11-3091-7209. Fax: 55-11-3091-7417. E-mail: hernando{at}icb.usp.br.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: J. F. Urban, Jr.

{ddagger} These authors contributed equally to this work.

§ Present address: DKFZ INF 280, 69120 Heidelberg, Germany.


Infection and Immunity, May 2006, p. 2726-2733, Vol. 74, No. 5
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.5.2726-2733.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Cole-Tobian, J. L., Michon, P., Biasor, M., Richards, J. S., Beeson, J. G., Mueller, I., King, C. L. (2009). Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean Children. Infect. Immun. 77: 4009-4017 [Abstract] [Full Text]  
  • Cadman, E. T., Abdallah, A. Y., Voisine, C., Sponaas, A.-M., Corran, P., Lamb, T., Brown, D., Ndungu, F., Langhorne, J. (2008). Alterations of Splenic Architecture in Malaria Are Induced Independently of Toll-Like Receptors 2, 4, and 9 or MyD88 and May Affect Antibody Affinity. Infect. Immun. 76: 3924-3931 [Abstract] [Full Text]  
  • Bastos, M. S., da Silva-Nunes, M., Malafronte, R. S., Hoffmann, E. H. E., Wunderlich, G., Moraes, S. L., Ferreira, M. U. (2007). Antigenic Polymorphism and Naturally Acquired Antibodies to Plasmodium vivax Merozoite Surface Protein 1 in Rural Amazonians. CVI 14: 1249-1259 [Abstract] [Full Text]